Suppr超能文献

一种新型食欲抑制剂(PM 170)对小鼠硫代葡萄糖金诱导肥胖症发展的影响。

Effects of a new anorectic drug (PM 170) on development of gold thioglucose-induced obesity in mice.

作者信息

Massicot F, Falcou R, Heymans F, Godfroid J J, Apfelbaum M

出版信息

Gen Pharmacol. 1987;18(3):249-52. doi: 10.1016/0306-3623(87)90007-3.

Abstract

Gold thioglucose (GTG)-injected mice and lean mice were treated for 16 days with PM 170. The body weight and body fat were significantly increased by GTG injection and these increases in the GTG-obese group were reduced by PM 170. PM 170 also reduced food intake (16%), total body triacylglycerol (51%) and total body cholesterol (36%). Basal lipolysis of white adipose tissue, as measured by glycerol release, was stimulated by 150%. Compared to GTG-PM 170 mice, body weight gain was 2 times higher in GTG-pair-fed mice. Body fat and total body lipid content remained elevated.

摘要

用硫代葡萄糖金(GTG)注射的小鼠和瘦小鼠用PM 170处理16天。GTG注射显著增加了体重和体脂,而PM 170降低了GTG肥胖组的这些增加量。PM 170还减少了食物摄入量(16%)、全身三酰甘油(51%)和全身胆固醇(36%)。通过甘油释放测量的白色脂肪组织基础脂解作用被刺激了150%。与GTG-PM 170小鼠相比,GTG配对喂养小鼠的体重增加高2倍。体脂和全身脂质含量仍然升高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验